VAHDAM India, a wellness brand known for bringing teas, herbs, and botanicals to global markets, has received a strategic equity investment of $3 million (~Rs 25 crore) from SIDBI Venture Capital.
From what is understood, this infusion of capital is not part of a formal funding round but is aimed at strengthening the company’s balance sheet and cash reserves. VAHDAM India remains well-capitalised and is poised to close the current fiscal year with strong growth and positive EBITDA.
“I am excited to welcome SIDBI Venture Capital to our capital table as we continue our journey of taking the finest Indian products to the world. The funds raised will strengthen our balance sheet and cash reserves. Over the past two years, we have focused on reinforcing our core, optimising our product portfolio, and identifying key levers for scale. The company is also making significant investments in product innovation, R&D, and expanding its in-house manufacturing capabilities. With a sharper focus and a more resilient foundation, we are well-positioned for sustained growth over the next three years,” Bala Sarda, founder and CEO, VAHDAM India, said.
Looking ahead, the company is set to close the financial year 2024-25 with net revenues exceeding Rs 265 crore, along with EBITDA profitability, it stated. With a focus on product innovation, research and development, and enhanced manufacturing capabilities, VAHDAM India aims to solidify its position as a global leader in premium wellness products.
“VAHDAM India is a pioneer and a flagbearer of young Indian companies taking homegrown products to the world through a disruptive supply chain model and strong operational capabilities. We are thrilled to invest in Bala and VAHDAM India as they continue to set new benchmarks in building a resilient and impactful business while driving significant innovation and value creation in India’s agricultural ecosystem,” Arup Kumar, managing director, SIDBI Ventures, commented.